Literature DB >> 12372790

Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells.

Violeta Alvarez1, Yasmir Quiroz, Mayerly Nava, Héctor Pons, Bernardo Rodríguez-Iturbe.   

Abstract

Recent evidence suggests that salt-sensitive hypertension develops as a consequence of renal infiltration with immunocompetent cells. We investigated whether proteinuria, which is known to induce interstitial nephritis, causes salt-sensitive hypertension. Female Lewis rats received 2 g of BSA intraperitoneally daily for 2 wk. After protein overload (PO), 6 wk of a high-salt diet induced hypertension [systolic blood pressure (SBP) = 156 +/- 11.8 mmHg], whereas rats that remained on a normal-salt diet and control rats (without PO) on a high-salt diet were normotensive. Administration of mycophenolate mofetil (20 mg. kg(-1). day(-1)) during PO resulted in prevention of proteinuria-related interstitial nephritis, reduction of renal angiotensin II-positive cells and oxidative stress (superoxide-positive cells and renal malondialdehyde content), and resistance to the hypertensive effect of the high-salt diet (SBP = 129 +/- 12.2 mmHg). The present studies support the participation of renal inflammatory infiltrate in the pathogenesis of salt-sensitive hypertension and provide a direct link between two risk factors of progressive renal damage: proteinuria and hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372790     DOI: 10.1152/ajprenal.00199.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  34 in total

Review 1.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

Review 2.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

3.  Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.

Authors:  Shireen Hashmat; Nathan Rudemiller; Hayley Lund; Justine M Abais-Battad; Scott Van Why; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-08

Review 4.  Renal inflammation, autoimmunity and salt-sensitive hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Martha Franco; Edilia Tapia; Yasmir Quiroz; Richard J Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-01       Impact factor: 2.557

5.  Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Erika I Boesen; Douglas L Williams; Jennifer S Pollock; David M Pollock
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-10       Impact factor: 2.557

Review 6.  The role of T cells in the pathogenesis of primary hypertension.

Authors:  Yasmir Quiroz; Richard J Johnson; Bernardo Rodríguez-Iturbe
Journal:  Nephrol Dial Transplant       Date:  2012-10-03       Impact factor: 5.992

7.  Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

Authors:  Yuri Ozawa; Hiroyuki Kobori; Yuki Suzaki; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-27

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

9.  Role of immune factors in angiotensin II-induced hypertension and renal damage in Dahl salt-sensitive rats.

Authors:  Brittany Wade; Galina Petrova; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-08       Impact factor: 3.619

10.  The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome.

Authors:  Xiao Shan Shao; Xi Qang Yang; Xiao Dong Zhao; Qiu Li; Yuan Yuan Xie; Xiao Gang Wang; Mo Wang; Wei Zhang
Journal:  Pediatr Nephrol       Date:  2009-06-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.